Exhibit 10.1


 





	
   

  	
   

  
	
   

  	
  Lawrence
  D. Stern

  
	
   

  	
  Chairman
  and CEO

  
	
   

  	
  Talecris
  Biotherapeutics, Inc.

  
	
   

  	
  79
  TW Alexander Drive

  
	
   

  	
  4101
  Research Commons

  
	
   

  	
  Research
  Triangle Park, NC 27709

  



 


May 25,
2010


 


John
Perkins


[      ]


[      ]


 


Dear
John,


 


I
am pleased to confirm that the Board of Directors has approved your promotion
to Executive Vice President, Global Commercial, Talecris Biotherapeutics (“Talecris”).
You will continue to report directly to me. This is a significant and
meaningful step forward in both the evolution of Talecris and your career. You
have consistently demonstrated an ability to think independently and
strategically, while also driving forward the required execution.


 


Your Position and Role


In
the role of Executive Vice President, Global Commercial, you will initially be
responsible for global sales, marketing and product management, including
product life cycle management. As an Executive Vice President, your role
includes shaping the overall strategies and execution plans together with other
members of our leadership team. From time to time, as I determine in the best
interests of the Corporation, you may be asked to assume additional duties
consistent with general expectations of an Executive Vice President. Also from
time to time, as I determine, we may further optimize groups, organizations and
roles and your overall span of either direct or indirect control. In this role,
you are of course expected to focus on risk management, culture and ethics in
addition to performance of the corporation.


 


Your Base Salary, Target Bonus and Equity Incentive Awards


Effective
the first full payroll period following your acceptance of this offer, your
adjusted base salary will be $420,000 paid in biweekly increments and your
target annual bonus will be 75% prorated based on your plan year eligible
earnings. As you are aware, funding for the Bonus program is based on a
combination of financial and other strategic goals and the Compensation
Committee of the Board will consider your individual performance in determining
your individual bonus award. Equity awards will be made at the discretion of
the Compensation Committee, consistent with other Executive Vice Presidents,
reflective of company and individual performance. The Compensation Committee of
the Board retains full discretion on the terms of the cash bonus plan and
equity awards.


 


Separation


You
are also eligible for additional severance pay and benefits as described in the
attached Separation Pay Agreement.


 


Contingencies


Please
be aware that this letter confirms that the offer of promotion is based on no
representations other than those set forth in this letter.


 

















 


To
confirm your acceptance of this promotion, please sign where indicated below
and return a copy of this letter along with the Separation Pay Agreement to
Kari Heerdt, SVP, Human Resources, so that we may place it in your personnel
file.


 


Sincerely,


 


 


Lawrence
D. Stern


Chairman
and CEO


Talecris
Biotherapeutics, Inc.


 


	
  cc:

  	
  Kari
  Heerdt, SVP Human Resources

  
	
   

  	
  File

  



 


I
accept the position of EVP, Global Commercial, within Talecris Biotherapeutics.


 


	
  /s/
  John Perkins

  	
   

  	
  5/27/10

  
	
  John
  Perkins

  	
   

  	
  Date

  



 


2